TGFB1 and neoplasm: The corresponding results showed that the interaction of exosomal ligands (including but not limited to TGF-b) with their cognate receptors on NK cells can induce multiple downstream inhibitory signaling pathways, suppressing their anti-tumor activity [23] (Fig. 1a).